A randomized, double-blind, placebo-controlled multicenter trial, assessing the impact of inclisiran on major adverse cardiovascular events in participants with established cardiovascular disease

  • STATUS
    Not Recruiting
Updated on 3 October 2022
stroke
hmg-coa reductase inhibitor
atherosclerotic cardiovascular disease

Summary

We are seeking participants for a clinical research study who have Atherosclerotic Cardiovascular Disease (thickening/hardening of the arteries which is caused by a buildup of plaque in the lining of an artery).This study is designed to evaluate the treatment of an investigational medication along with a well-tolerated statin therapy (lipid lowering medication). The goal is to help reduce the risks of Cardiovascular Disease such as heart attacks and strokes. 

Description

  • Reimbursement for time and travel
  • You are provided study-related care and study medicine at no cost (no health insurance required)
  • Looking for participants within a 30 mile radius of the study site.

Details
Condition High Cholesterol (Hyperlipidemia), Cardiovascular Disease
Clinical Study IdentifierTX294799
Last Modified on3 October 2022

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note